From Infojustice.org: “[PIJIP] Last week, the report Brazilian Patent Reform: Innovation Towards Competitiveness was launched at an event at the Brazilian Chamber of Deputies. This report was developed through a long consultative process (including seven workshops in 2011 and 2012) by a technical team led by FGV’s Pedro Paranaguá. It proposes legislative reforms that would incorporate lawful TRIPS flexibilities into domestic law, enhancing access to generic medicines. Proposed reforms include: eliminating patent term extensions and data exclusivity, restricting patents on new forms and new uses and tightening the inventive step requirement (following the India example), adopting a government use procedures, and clarifying the role that ANVISA, its drug regulatory agency, plays in the patent examination system. Click here for more.”
[FGV is the Fundação Getulio Vargas law school in Rio de Janeiro. TRIPS is the World Trade Organization Agreement on Trade-Related Aspects of Intellectual Property Rights.]